Search for: "Houck " Results 81 - 100 of 272
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Aug 2011, 3:31 pm
The bill was introduced after Raechel and Jacqueline Houck died in a car crash because their PT cruiser rental had a power steering defect that increased the risk of an engine fire occurring. [read post]
17 Aug 2011, 3:31 pm
The bill was introduced after Raechel and Jacqueline Houck died in a car crash because their PT cruiser rental had a power steering defect that increased the risk of an engine fire occurring. [read post]
7 Apr 2012, 1:51 pm by Dwight Sullivan
Houck, No. 12-5038 (the complete brief is available here): A. [read post]
22 Dec 2010, 8:30 pm by Dwight Sullivan
Houck, No. 1:10-cv-01962-HHK, in the United States District Court for the District of Columbia. [read post]
23 May 2012, 3:25 am by Robert Kraft
My friend Darren Houck is a partner at September Services, one of the best of the home health care companies. [read post]
10 Apr 2023, 5:59 pm by Kurt R. Karst
Houck —Drugs and substances classified within schedule I of the federal Controlled Substances Act (“CSA”) by definition have a high potential for abuse, no currently accepted medical use in treatment in the United States, and lack accepted safety for use under medical supervision. [read post]
19 Apr 2022, 9:34 pm by Kurt R. Karst
Houck —Effective May 11, 2022, the Drug Enforcement Administration (“DEA”) will require all applications and renewals for registration to be submitted electronically. [read post]
2 May 2022, 6:30 pm by Kurt R. Karst
Houck —Last week, Attorney General Merrick Garland reiterated the position expressed during his confirmation hearing that enforcement of marijuana cases in states where activities are legal is an inefficient use of Department of Justice (“DOJ”) resources. [read post]
12 Jul 2011, 4:41 pm by FDABlog HPM
Houck – The Drug Enforcement Administration (“DEA”) published a Notice of Proposed Rulemaking (“NPRM”) on July 6, 2011 seeking to raise initial registration and renewal fees for all registrants. [read post]
9 Aug 2023, 6:00 pm by Kurt R. Karst
Houck —If a patient presents a paper prescription for a controlled substance to a pharmacy and the pharmacy cannot fill it, the patient can take that prescription to another pharmacy. [read post]
15 Mar 2012, 4:40 pm by FDABlog HPM
Houck – The Drug Enforcement Administration (“DEA”) has published a Final Rule increasing initial registration and renewal fees for all registrants. [read post]
10 Nov 2022, 10:36 pm by Kurt R. Karst
Houck —When you have followed Drug Enforcement Administration (“DEA”)/Department of Justice (“DOJ”) civil settlements for as long as we have, you cannot help but think that you’ve seen it all. [read post]
26 Jun 2023, 1:37 am by Kurt R. Karst
Houck —The Drug Enforcement Administration (“DEA”) has designated precursor chemicals, including 4-piperidone just last month, used in the illicit manufacture of controlled substances as List I and II chemicals over the years as “laboratory supplies,” but has never revised or updated its Special Surveillance List. [read post]
30 Oct 2023, 5:44 pm by Kurt R. Karst
Houck —The Drug Enforcement Administration (“DEA”) has issued its notice finalizing updates to its longstanding Special Surveillance List of chemicals and equipment used in the illicit manufacture of controlled substances and listed chemicals. [read post]
21 Feb 2023, 6:25 pm by Kurt R. Karst
Houck —Last October, President Joe Biden directed the Secretary of Health and Human Services (“HHS”) and the Attorney General to begin the administrative process of reviewing current marijuana scheduling under federal law. [read post]
22 Apr 2024, 7:06 pm by Kurt R. Karst
Houck —Administrator Anne Milgram has been on the receiving end of high-level support for and against rescheduling marijuana since the Food and Drug Administration (“FDA”) and Health and Human Services (“HHS”) recommended the Drug Enforcement Administration (“DEA”) reschedule from schedule I to schedule III last August. [read post]
16 May 2024, 4:02 pm by Kurt R. Karst
Houck —Employee diversion of controlled substances from hospitals has been an issue since at least 1986 when I became a diversion investigator with the Drug Enforcement Administration (“DEA”). [read post]